These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rebound weight gain as associated with high plasma norepinephrine levels that are mediated through polymorphisms in the beta2-adrenoceptor. Masuo K, Katsuya T, Kawaguchi H, Fu Y, Rakugi H, Ogihara T, Tuck ML. Am J Hypertens; 2005 Nov; 18(11):1508-16. PubMed ID: 16280290 [Abstract] [Full Text] [Related]
5. Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients. Faria AN, Ribeiro Filho FF, Kohlmann NE, Gouvea Ferreira SR, Zanella MT. Diabetes Obes Metab; 2005 May; 7(3):246-53. PubMed ID: 15811141 [Abstract] [Full Text] [Related]
6. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension. Golan E, Tal B, Dror Y, Korzets Z, Vered Y, Weiss E, Bernheim J. Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415 [Abstract] [Full Text] [Related]
7. Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension. Fogari R, Zoppi A, Corradi L, Preti P, Mugellini A, Lazzari P, Derosa G. Hypertens Res; 2010 Mar; 33(3):236-42. PubMed ID: 20075930 [Abstract] [Full Text] [Related]
12. Weight loss induced by nutritional and exercise intervention decreases arterial stiffness in obese subjects. Goldberg Y, Boaz M, Matas Z, Goldberg I, Shargorodsky M. Clin Nutr; 2009 Feb; 28(1):21-5. PubMed ID: 19019502 [Abstract] [Full Text] [Related]
13. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects. de Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O. Ann Nutr Metab; 2007 Feb; 51(2):134-8. PubMed ID: 17536190 [Abstract] [Full Text] [Related]
14. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. Fagerberg B, Berglund A, Andersson OK, Berglund G. J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365 [Abstract] [Full Text] [Related]
15. Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. Lambert E, Straznicky N, Eikelis N, Esler M, Dawood T, Masuo K, Schlaich M, Lambert G. J Hypertens; 2007 Jul; 25(7):1411-9. PubMed ID: 17563563 [Abstract] [Full Text] [Related]
17. Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. Fogari R, Derosa G, Zoppi A, Rinaldi A, Lazzari P, Fogari E, Mugellini A, Preti P. Hypertens Res; 2005 Mar; 28(3):209-14. PubMed ID: 16097363 [Abstract] [Full Text] [Related]
18. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch-Gavan M, Nagelberg N, Karni Y, Hershkovitz E, Loewenthal N, Shtaif B, Gat-Yablonski G, Phillip M. Horm Res; 2009 Mar; 72(5):287-301. PubMed ID: 19844115 [Abstract] [Full Text] [Related]
19. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT. Obes Res; 2002 Dec; 10(12):1203-6. PubMed ID: 12490663 [Abstract] [Full Text] [Related]
20. Changes in multiple health outcomes at 12 and 24 weeks resulting from 12 weeks of exercise counseling with or without dietary counseling in obese adults. Melanson KJ, Dell'Olio J, Carpenter MR, Angelopoulos TJ. Nutrition; 2004 Oct; 20(10):849-56. PubMed ID: 15474871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]